Last $2.82 USD
Change Today +0.07 / 2.55%
Volume 38.9K
CPXX On Other Exchanges
As of 5:20 PM 09/16/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Todd C. Brady M.D., Ph.D.

Chief Executive Officer, President and Director, Aldeyra Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 78 board members in 11 different organizations across 12 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. Todd C. Brady, M.D., Ph.D., serves as an Advisor to Leader Ventures since 2011, Dr. Brady has been the Chief Executive Officer and President at Aldeyra Therapeutics, Inc. since January 2012 and he also served as its Principal financial and accounting officer. He is a Co-Founder of Phenome Sciences and serves as its Chief Executive Officer. Dr. Brady serves as a Senior Advisor at Solidus Investment Co., Ltd. He was an Entrepreneur-In-Residence at Domain Associates, ...

Read Full Background

Corporate Headquarters*

200 PrincetonSouth Corporate Center
Ewing, New Jersey 08628

United States

Phone: 609-243-0123
Fax: 609-243-0202

Board Members Memberships*

Board Observer
Board Observer
Board Observer
Board Observer
Chief Executive Officer, President and Director
Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee


BA 1993
Dartmouth College
PhD 1998
Duke University
MD 1999
Duke University Medical Center
PhD 1998
The Graduate School, Duke University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$70,833

Stock Options*

Restricted Stock Awards$136,732
Exercisable Options32,953
Unexercisable Options288,126
Total Number of Options369,100

Total Compensation*

Total Annual Cash Compensation$70,833
Total Short Term Compensation$70,833
Other Long Term Compensation$136,732
Total Calculated Compensation$3,687,821
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CPXX:US $2.82 USD +0.07


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELATOR PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at